Larvol Delta - DoseEscalation-and-DoseExpansion-Study-of-BSI082-Monotherapy-and-Combined-Therapy-in-Patients-With-Advanced-or-Metastatic-Solid-Tumors

Enhertu (fam-trastuzumab deruxtecan-nxki) - Daiichi Sankyo, AstraZeneca

BSI-082 - Biosion

http://clinicaltrials.gov/ct2/show/NCT07086768

Jun 4, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next